CN105362513A - Traditional Chinese medicine composition for treating lung cancer - Google Patents
Traditional Chinese medicine composition for treating lung cancer Download PDFInfo
- Publication number
- CN105362513A CN105362513A CN201510948175.XA CN201510948175A CN105362513A CN 105362513 A CN105362513 A CN 105362513A CN 201510948175 A CN201510948175 A CN 201510948175A CN 105362513 A CN105362513 A CN 105362513A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- polyporus
- medicine composition
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention discloses a traditional Chinese medicine composition for treating lung cancer. The traditional Chinese medicine composition for treating the lung cancer is prepared from, by weight, 10-20 parts of selfheal, 10-20 parts of longhairy antenoron herb, 10-20 parts of dandelions, 10-20 parts of honeysuckle stems, 1-10 parts of goldthread roots, 5-15 parts of flos eriocauli, 10-20 parts of frankincense, 5-15 parts of pepper, 5-15 parts of licorice roots, 10-20 parts of polyporus and 5-15 parts of Japanese flowering fern rhizomes. All the components of the traditional Chinese medicine composition are interacted and act in a synergistic mode, and the curative effect is significant; cancer cells can be effectively poisoned and killed, and meanwhile the autoimmunity function of a body can be improved.
Description
Technical field
The present invention is specifically related to a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
Background technology
It is the fastest that pulmonary carcinoma is that M & M increases, to one of population health and the maximum malignant tumor of life threat.The many countries of immediate and mid-term all report that the M & M of pulmonary carcinoma all obviously increases, and male lung cancer M & M all accounts for first of all malignant tumor, and women's sickness rate accounts for second, and mortality rate accounts for second.
Because lung cancer morbidity is fast, patient is more than 80% without the condition of excision making a definite diagnosis, therefore modern Western medicine treatment pulmonary carcinoma many employings chemotherapy or radiation therapy, while killing cancerous cell, also many for human body normal cells are eliminated together, the reason reducing the resistance of human body, this easily shifts for cancer, recur; In the case of western medicine therapy, later stage relapse rate is higher, and five year survival rate is very low.
Summary of the invention
For solving the problem, the invention provides a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
The present invention is achieved through the following technical solutions:
Treat a Chinese medicine composition for pulmonary carcinoma, described compositions is made up of the raw material of following weight portion: Spica Prunellae 10 ~ 20 parts, Herba Lysimachiae 10 ~ 20 parts, Herba Taraxaci 10 ~ 20 parts, Caulis Lonicerae 10 ~ 20 parts, Rhizoma Coptidis 1 ~ 10 part, paddy essence 5 ~ 15 parts, Olibanum 10 ~ 20 parts, 5 ~ 15 parts, Pericarpium Zanthoxyli, 5 ~ 15 parts, Radix Glycyrrhizae, Polyporus 10 ~ 20 parts, Rhizoma Osmundae 5 ~ 15 parts.
Particularly, described compositions comprises following six kinds of schemes:
Scheme one: Spica Prunellae 12 parts, Herba Lysimachiae 17 parts, Herba Taraxaci 13 parts, Caulis Lonicerae 16 parts, Rhizoma Coptidis 3 parts, paddy essence 8 parts, Olibanum 12 parts, 7 parts, Pericarpium Zanthoxyli, 13 parts, Radix Glycyrrhizae, Polyporus 12 parts, Rhizoma Osmundae 11 parts;
Scheme two: Spica Prunellae 16 parts, Herba Lysimachiae 13 parts, Herba Taraxaci 17 parts, Caulis Lonicerae 12 parts, Rhizoma Coptidis 8 parts, paddy essence 11 parts, Olibanum 18 parts, 13 parts, Pericarpium Zanthoxyli, 7 parts, Radix Glycyrrhizae, Polyporus 16 parts, Rhizoma Osmundae 6 parts;
Scheme three: Spica Prunellae 14 parts, Herba Lysimachiae 11 parts, Herba Taraxaci 18 parts, Caulis Lonicerae 11 parts, Rhizoma Coptidis 7 parts, paddy essence 13 parts, Olibanum 16 parts, 12 parts, Pericarpium Zanthoxyli, 6 parts, Radix Glycyrrhizae, Polyporus 18 parts, Rhizoma Osmundae 8 parts;
Scheme four: Spica Prunellae 18 parts, Herba Lysimachiae 19 parts, Herba Taraxaci 11 parts, Caulis Lonicerae 18 parts, Rhizoma Coptidis 2 parts, paddy essence 6 parts, Olibanum 14 parts, 9 parts, Pericarpium Zanthoxyli, 12 parts, Radix Glycyrrhizae, Polyporus 14 parts, Rhizoma Osmundae 13 parts;
Scheme five: Spica Prunellae 15 parts, Herba Lysimachiae 15 parts, Herba Taraxaci 15 parts, Caulis Lonicerae 15 parts, Rhizoma Coptidis 5 parts, paddy essence 10 parts, Olibanum 15 parts, 10 parts, Pericarpium Zanthoxyli, 10 parts, Radix Glycyrrhizae, Polyporus 15 parts, Rhizoma Osmundae 10 parts;
Scheme six: Spica Prunellae 11 parts, Herba Lysimachiae 12 parts, Herba Taraxaci 16 parts, Caulis Lonicerae 17 parts, Rhizoma Coptidis 9 parts, paddy essence 7 parts, Olibanum 17 parts, 6 parts, Pericarpium Zanthoxyli, 14 parts, Radix Glycyrrhizae, Polyporus 17 parts, Rhizoma Osmundae 12 parts.
Further, when described compositions is taken, take with brown sugar.
The present invention has the following advantages and beneficial effect:
Each raw material of the present invention influences each other, and synergism is evident in efficacy; Effectively can kill cancerous cell, body autoimmune function can be improved simultaneously.
Compositions of the present invention also has the effect of separating hydrargyrum, can treat the patient of mercurialism, also can treat other diseases caused because of hydrargyrum.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, but embodiments of the present invention are not limited to this.
Embodiment 1
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 12 parts, the Herba Lysimachiae of 17 parts, the Herba Taraxaci of 13 parts, the Caulis Lonicerae of 16 parts, the Rhizoma Coptidis of 3 parts, paddy essence, the Olibanum of 12 parts, the Pericarpium Zanthoxyli of 7 parts, the Radix Glycyrrhizae of 13 parts, the Polyporus of 12 parts, the Rhizoma Osmundae of 11 parts of 8 parts make.Preparation method is that above-mentioned raw materials is ground to form powdery by traditional handicraft particularly, and mixes in proportion.
Embodiment 2
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 16 parts, the Herba Lysimachiae of 13 parts, the Herba Taraxaci of 17 parts, the Caulis Lonicerae of 12 parts, the Rhizoma Coptidis of 8 parts, paddy essence, the Olibanum of 18 parts, the Pericarpium Zanthoxyli of 13 parts, the Radix Glycyrrhizae of 7 parts, the Polyporus of 16 parts, the Rhizoma Osmundae of 6 parts of 11 parts make.Its preparation method is identical with embodiment 1.
Embodiment 3
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 14 parts, the Herba Lysimachiae of 11 parts, the Herba Taraxaci of 18 parts, the Caulis Lonicerae of 11 parts, the Rhizoma Coptidis of 7 parts, paddy essence, the Olibanum of 16 parts, the Pericarpium Zanthoxyli of 12 parts, the Radix Glycyrrhizae of 6 parts, the Polyporus of 18 parts, the Rhizoma Osmundae of 8 parts of 13 parts make.Its preparation method is identical with embodiment 1.
Embodiment 4
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 18 parts, the Herba Lysimachiae of 19 parts, the Herba Taraxaci of 11 parts, the Caulis Lonicerae of 18 parts, the Rhizoma Coptidis of 2 parts, paddy essence, the Olibanum of 14 parts, the Pericarpium Zanthoxyli of 9 parts, the Radix Glycyrrhizae of 12 parts, the Polyporus of 14 parts, the Rhizoma Osmundae of 13 parts of 6 parts make.Its preparation method is identical with embodiment 1.
Embodiment 5
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 15 parts, the Herba Lysimachiae of 15 parts, the Herba Taraxaci of 15 parts, the Caulis Lonicerae of 15 parts, the Rhizoma Coptidis of 5 parts, paddy essence, the Olibanum of 15 parts, the Pericarpium Zanthoxyli of 10 parts, the Radix Glycyrrhizae of 10 parts, the Polyporus of 15 parts, the Rhizoma Osmundae of 10 parts of 10 parts make.Its preparation method is identical with embodiment 1.
Embodiment 6
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 11 parts, the Herba Lysimachiae of 12 parts, the Herba Taraxaci of 16 parts, the Caulis Lonicerae of 17 parts, the Rhizoma Coptidis of 9 parts, paddy essence, the Olibanum of 17 parts, the Pericarpium Zanthoxyli of 6 parts, the Radix Glycyrrhizae of 14 parts, the Polyporus of 17 parts, the Rhizoma Osmundae of 12 parts of 7 parts make.Its preparation method is identical with embodiment 1.
Embodiment 7
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 10 parts, the Herba Lysimachiae of 20 parts, the Herba Taraxaci of 10 parts, the Caulis Lonicerae of 20 parts, the Rhizoma Coptidis of 10 parts, paddy essence, the Olibanum of 10 parts, the Pericarpium Zanthoxyli of 15 parts, the Radix Glycyrrhizae of 15 parts, the Polyporus of 10 parts, the Rhizoma Osmundae of 5 parts of 5 parts make.Its preparation method is identical with embodiment 1.
Embodiment 8
Treat a Chinese medicine composition for pulmonary carcinoma, said composition be by weight portion be the Spica Prunellae of 20 parts, the Herba Lysimachiae of 10 parts, the Herba Taraxaci of 20 parts, the Caulis Lonicerae of 10 parts, the Rhizoma Coptidis of 4 parts, paddy essence, the Olibanum of 20 parts, the Pericarpium Zanthoxyli of 5 parts, the Radix Glycyrrhizae of 5 parts, the Polyporus of 20 parts, the Rhizoma Osmundae of 15 parts of 15 parts make.Its preparation method is identical with embodiment 1.
Instructions of taking: compositions of the present invention coordinated with brown sugar water and take, reality takes with brown sugar water exactly, and the weight ratio of its compositions and brown sugar water is 4:5.Specifically can get 4g by reference group compound, brown sugar water is got 5g and is taken, every day three times.
Clinical trial:
Clinical research enters to organize patient 85 example altogether, is all the lung cancer patient that the inspection of modern medicine x-ray and CT examination are made a definite diagnosis; According to body weight and the age increase and decrease as one sees fit of patient, three times on the one 30 days is a course for the treatment of.Result is that obvious effective rate reaches 27%, and total effective rate reaches 49%, during data, toxic and side effects does not occur.
Typical case:
Wang, man, 40 years old, because feeling of oppression and pain in the chest is to examination in hospital, is diagnosed as alveolar cell carcinoma.Through chemotherapy without positive effect, be clearly better after adopting compositions of the present invention to take 3 courses for the treatment of continuously, pulmonary shadow reduces, and continue to take 6 courses for the treatment of, pulmonary shadow disappears completely.
Lee, female, 55 years old, because of irritable cough companion sputum with blood streaks, suffocating pain over the chest, asthma, tumour hospital of generating heat.Be diagnosed as in right lung on inspection and break up squamous cell carcinoma.Adopt compositions of the present invention to take 1 course for the treatment of continuously, cough alleviates, and after continuing to take 2 courses for the treatment of, the state of an illness is clearly better, and after continuing to take 2 courses for the treatment of, all symptoms all disappear, and continues to take 1 course for the treatment of, cancerous cell foci disappearance, so far without recurrence.
Liu, man, 60 years old, patient had the smoking history of decades, and symptom cough, sputum mixed with blood, the symptoms such as chest pain, carry out inspection to hospital and be diagnosed as pulmonary carcinoma.Take compositions of the present invention, 1 course for the treatment of, symptom is all to be alleviated, and continue to take 2 courses for the treatment of, all symptoms are clearly better, and after continuing to take 1 course for the treatment of, transference cure, antisecosis, continue to take 3 courses for the treatment of, all symptoms all disappear, so far without recurrence.
Should be noted that, above embodiment is the unrestricted technical scheme of the present invention in order to explanation only, although with reference to above-described embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that: still can modify to the present invention or equivalent replacement, and not departing from any modification or partial replacement of the spirit and scope of the present invention, it all should be encompassed in right of the present invention.
Claims (3)
1. treat the Chinese medicine composition of pulmonary carcinoma for one kind, it is characterized in that, described compositions is made up of the raw material of following weight portion: Spica Prunellae 10 ~ 20 parts, Herba Lysimachiae 10 ~ 20 parts, Herba Taraxaci 10 ~ 20 parts, Caulis Lonicerae 10 ~ 20 parts, Rhizoma Coptidis 1 ~ 10 part, paddy essence 5 ~ 15 parts, Olibanum 10 ~ 20 parts, 5 ~ 15 parts, Pericarpium Zanthoxyli, 5 ~ 15 parts, Radix Glycyrrhizae, Polyporus 10 ~ 20 parts, Rhizoma Osmundae 5 ~ 15 parts.
2. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, is characterized in that, described compositions comprises following six kinds of schemes:
Scheme one: Spica Prunellae 12 parts, Herba Lysimachiae 17 parts, Herba Taraxaci 13 parts, Caulis Lonicerae 16 parts, Rhizoma Coptidis 3 parts, paddy essence 8 parts, Olibanum 12 parts, 7 parts, Pericarpium Zanthoxyli, 13 parts, Radix Glycyrrhizae, Polyporus 12 parts, Rhizoma Osmundae 11 parts;
Scheme two: Spica Prunellae 16 parts, Herba Lysimachiae 13 parts, Herba Taraxaci 17 parts, Caulis Lonicerae 12 parts, Rhizoma Coptidis 8 parts, paddy essence 11 parts, Olibanum 18 parts, 13 parts, Pericarpium Zanthoxyli, 7 parts, Radix Glycyrrhizae, Polyporus 16 parts, Rhizoma Osmundae 6 parts;
Scheme three: Spica Prunellae 14 parts, Herba Lysimachiae 11 parts, Herba Taraxaci 18 parts, Caulis Lonicerae 11 parts, Rhizoma Coptidis 7 parts, paddy essence 13 parts, Olibanum 16 parts, 12 parts, Pericarpium Zanthoxyli, 6 parts, Radix Glycyrrhizae, Polyporus 18 parts, Rhizoma Osmundae 8 parts;
Scheme four: Spica Prunellae 18 parts, Herba Lysimachiae 19 parts, Herba Taraxaci 11 parts, Caulis Lonicerae 18 parts, Rhizoma Coptidis 2 parts, paddy essence 6 parts, Olibanum 14 parts, 9 parts, Pericarpium Zanthoxyli, 12 parts, Radix Glycyrrhizae, Polyporus 14 parts, Rhizoma Osmundae 13 parts;
Scheme five: Spica Prunellae 15 parts, Herba Lysimachiae 15 parts, Herba Taraxaci 15 parts, Caulis Lonicerae 15 parts, Rhizoma Coptidis 5 parts, paddy essence 10 parts, Olibanum 15 parts, 10 parts, Pericarpium Zanthoxyli, 10 parts, Radix Glycyrrhizae, Polyporus 15 parts, Rhizoma Osmundae 10 parts;
Scheme six: Spica Prunellae 11 parts, Herba Lysimachiae 12 parts, Herba Taraxaci 16 parts, Caulis Lonicerae 17 parts, Rhizoma Coptidis 9 parts, paddy essence 7 parts, Olibanum 17 parts, 6 parts, Pericarpium Zanthoxyli, 14 parts, Radix Glycyrrhizae, Polyporus 17 parts, Rhizoma Osmundae 12 parts.
3. a kind of Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1 and 2, is characterized in that, when described compositions is taken, take with brown sugar water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510948175.XA CN105362513A (en) | 2015-12-17 | 2015-12-17 | Traditional Chinese medicine composition for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510948175.XA CN105362513A (en) | 2015-12-17 | 2015-12-17 | Traditional Chinese medicine composition for treating lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105362513A true CN105362513A (en) | 2016-03-02 |
Family
ID=55365462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510948175.XA Pending CN105362513A (en) | 2015-12-17 | 2015-12-17 | Traditional Chinese medicine composition for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105362513A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018210224A1 (en) * | 2017-05-15 | 2018-11-22 | 王晓辉 | Applications of triptolide and derivative thereof in preparing medicament for treating and/or preventing lung-damaging diseases |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600298A (en) * | 2012-03-28 | 2012-07-25 | 佟森 | Traditional Chinese medicine for treating lung cancer and application of the medicine |
-
2015
- 2015-12-17 CN CN201510948175.XA patent/CN105362513A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600298A (en) * | 2012-03-28 | 2012-07-25 | 佟森 | Traditional Chinese medicine for treating lung cancer and application of the medicine |
Non-Patent Citations (2)
| Title |
|---|
| 富琦: "郁仁存应用清热解毒药物治疗肿瘤经验", 《中医杂志》 * |
| 曾学文: "复方金钱草合剂治疗汞中毒31例", 《江苏中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018210224A1 (en) * | 2017-05-15 | 2018-11-22 | 王晓辉 | Applications of triptolide and derivative thereof in preparing medicament for treating and/or preventing lung-damaging diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103893738B (en) | A kind of suppression tumor growth Chinese medicine composition and preparation method thereof | |
| Xue et al. | Activity of DBXX granules on anti-gastric ulcer and decreasing the side effect of chemotherapy in S180 tumor-bearing mice | |
| CN105168723B (en) | A topical Chinese medicinal composition for treating cancer pain, and its preparation method | |
| CN105362513A (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN104888149B (en) | The drug and its preparation process for treating cervical carcinoma | |
| CN103585364A (en) | Traditional Chinese medicine formula for treating intestinal cancer | |
| CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
| CN106266972A (en) | A kind of Chinese medicine formula treating pulmonary carcinoma | |
| CN105168259A (en) | Formulated traditional Chinese medicine composition for preventing and/or treating tumors, traditional Chinese medicine preparation and application | |
| CN103784689A (en) | Medicinal composition for treating leukemia | |
| CN104274706A (en) | Traditional Chinese medicine mixture for treating radioactive stomatitis | |
| CN109821002A (en) | A kind of Chinese herbs paste suitable for cancer pain | |
| CN103505670A (en) | Traditional Chinese medicine composition for treating primary bronchus lung cancer | |
| CN107184906A (en) | Chinese medicine composition for treating dysmenorrhoea and preparation method thereof | |
| CN105434890A (en) | Radiation stomatitis treating traditional Chinese medicine composition | |
| CN106265915A (en) | A kind of Chinese medicine composition treating prostatic hyperplasia | |
| CN104383087A (en) | Medicament for treating skin eczema | |
| CN105395940A (en) | Chinese medicinal composition mainly treating hemifacial spasm and preparation method | |
| CN102626470B (en) | Medicine for treating acne | |
| CN105079580A (en) | Traditional Chinese medicine composition for treating wind-warm lung-heat disease | |
| CN104435979B (en) | A kind of medicine for treating rheumatic lumbocrural pain pain | |
| CN104435309A (en) | Traditional Chinese medicine composition for treating costal chondritis and preparation method thereof | |
| CN104398793A (en) | Traditional Chinese medicine composition for treating radiation pneumonitis and preparation method of traditional Chinese medicine composition | |
| CN104013713B (en) | A kind of Chinese medicine preparation for the treatment of beriberi | |
| CN104000992A (en) | Traditional Chinese medicine composition for treating bladder cancer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160302 |